XENON PHARMACEUTICALS INC
XENON PHARMACEUTICALS INC
Action · CA98420N1050 · XENE · A12ETN (XNMS)
Aperçu Indicateurs financiers
31,64 USD
2,96 % 0,91 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 20:00

Cours actuels de XENON PHARMACEUTICALS INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
XENE
USD
06.06.2025 20:00
31,64 USD
30,73 USD
+2,96 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 9,67 % -10,06 % -15,20 % -25,94 % -16,36 % 167,46 %

Profil de l'entreprise pour XENON PHARMACEUTICALS INC Action

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Fonds investis

Les fonds suivants ont investi dans : XENON PHARMACEUTICALS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
25,16
Part (%)
0,06 %

Données de l'entreprise

Nom XENON PHARMACEUTICALS INC
Société Xenon Pharmaceuticals Inc.
Symbole XENE
Site web https://www.xenon-pharma.com
Marché d'origine XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A12ETN
ISIN CA98420N1050
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Capitalisation boursière 3 Mrd.
Pays Canada
Devise USD
Employés 0,3 T
Adresse 3650 Gilmore Way, V5G 4W8 Burnaby
Date d'introduction en bourse 2014-11-05

Symboles boursiers

Nom Symbole
Frankfurt XP0.F
NASDAQ XENE

Autres actions

Les investisseurs qui détiennent XENON PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DEXCO INC
DEXCO INC Action
Fidelity Total International Index Fund
Fidelity Total International Index Fund Fonds
GOLD ROYALTY CORP
GOLD ROYALTY CORP Action
HANSAINTERNATIONAL CL. A
HANSAINTERNATIONAL CL. A Fonds
INTEL CORP
INTEL CORP Action
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Action
MICROSOFT CORP
MICROSOFT CORP Action
NETFLIX INC
NETFLIX INC Action
OCCIDENTAL PETROLEUM CORP
OCCIDENTAL PETROLEUM CORP Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025